Dr. Steven Abraham Kaplan, MD

Dr. Kaplan practices at Urology Department of Mount Sinai in New York, New York.

Dr. Kaplan's NPI, 1932296019, was assigned on October 9, 2006. Dr. Kaplan graduated from Icahn School Of Medicine At Mount Sinai in 1982. Dr. Kaplan's New York license number on file is 155937.

Dr. Kaplan's primary practice is Urology Department of Mount Sinai, at 625 Madison Ave, New York, NY 10022 in New York County. The practice phone is (212) 241-4812.

Dr. Kaplan's primary practice is Urology Department of Mount Sinai in New York, New York. Dr. Kaplan is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Kaplan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kaplan is board certified in urology by the American Board of Urology. Dmand AI has Dr. Kaplan's licenses on file in 2 states: New York and Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, prostate cancer, testicular dysfunction, urinary endoscopy and UTI among the conditions Dr. Kaplan treats.

CMS data shows 5,193 Medicare services from Dr. Kaplan across 25 procedure codes in 2024, for 777 Medicare patients. Medicare paid $473,148 for them.

CMS counts 777 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 65 to 74, with 375 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 71, with 2% women.

In 2024, Dr. Kaplan wrote 1,687 Medicare Part D claims for 487 patients. 87% of them were for generic drugs. CMS names the drug for 1,600 of them, across 19 drugs with 11 or more claims each, at $183,886 in total drug cost. In 2023, CMS named 1,741 claims across 23 drugs.

Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaplan as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Kaplan, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 504 papers to Dr. Kaplan, published from 2006 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Urination Disorders. Dr. Kaplan has published most often in J Urol. Dr. Kaplan's most frequent co-authors are Bilal Iftikhar Chughtai, MD, Richard K. Lee, MD and Claus G. Roehrborn, MD.

Dmand AI links Dr. Kaplan to 1 clinical trial. Conditions studied include Glucose Intolerance and Hyperglycemia.

CMS Open Payments shows 104 general payments to Dr. Kaplan from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Laborie Medical Technologies Corp. paid the most, $19,449. It also lists 26 research payments totaling $18,636 from 2019 to 2020.

Dmand AI lists 15 awards for Dr. Kaplan, most recently Best Doctors in New York in 2014.

Dr. Kaplan graduated from Icahn School Of Medicine At Mount Sinai in 1982.

Dr. Kaplan is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.